STEPHANIE GUIZE: Open Payments
NPI 1104933886 · WEST AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,129 in 67 payments from 17 companies in 2025. Trend: 2023 $1,342 · 2024 $1,839 · 2025 $1,129
Food & beverage: $1,129
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 14 | $200 |
| Novo Nordisk Inc | 11 | $189 |
| Lilly USA, LLC | 10 | $115 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $97 |
| GlaxoSmithKline, LLC. | 6 | $94 |
| Edwards Lifesciences Corporation | 3 | $70 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $60 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $49 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Astellas Pharma US Inc | 2 | $44 |
Products named: Wegovy, NURTEC ODT, CAPLYTA, MOUNJARO, TRELEGY ELLIPTA, JARDIANCE, Kerendia, XIFAXAN.
Industry payments across NY — which companies pay providers there.
